TwinStrand Biosciences Enters Agreement With Exact Sciences To Exclusively License Its Patent Estate In The Cell Free Nucleic Acid Sequencing Space
Author: Benzinga Newsdesk | July 31, 2024 04:14pm
The license is related to TwinStrand Duplex Sequencing® error-correction technology, which increases the accuracy of next-generation sequencing by as much as 10,000 times, allowing the detection of ultra-low frequency mutations that would otherwise be hidden by technical noise inherent to the sequencing process.
Posted In: EXAS